Skip to Main Content

Chapter 1 explains the nature of speculative, financialized, multinational pharmaceutical capital. It focuses primarily on the logics that drive the Euro-American, R&D-driven pharmaceutical industry, to argue how an industry that is captured by capital is one that, structurally and constitutively, comes to be in crisis. I show how this crisis extends globally, implicating other national industries as well as consumers and patients in both the First World and the Third.

This content is only available as PDF.
Don't already have an account? Register
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal